In HFD-treated Nod1beta-cko mice, glucose intolerance was exacerbated compared to HFD-treated control mice (Supplementary Information, Fig. S8b, c) and less insulin was secreted upon glucose challenge in vivo (Supplementary Information, Fig. S8d). The gene discussed is INS; the disease is Glucose intolerance.